抗血小板药物与胃肠黏膜损伤的研究进展  

Research Progress of Anti-platelet Drugs and Gastrointestinal Mucosal Injury

作　　者：刘宇超[1] 郭春林[1] 丁瑞峰[2] 

机构地区：[1]包头医学院,内蒙古包头014010 [2]内蒙古科技大学包头医学院第一附属医院

出　　处：《中外医学研究》2017年第5期136-138,共3页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：膳食结构不合理、社会人口老龄化均使得心脑血管疾病高发,服用抗血小板药物者骤增,其中氯吡格雷和阿司匹林使用率最高。虽然有很多研究表明服用抗血小板药物后会出现胃肠黏膜损伤的症状,但是很少有报道分别阐明服用抗血小板药物后出现消化系症状和未出现消化系症状的患者其胃肠黏膜损伤的情况,这对未病先防有很大贡献。Unreasonable dietary structure and the aging of the social population have made the high incidence of cardiovascular and cerebrovascular diseases, so more and more patients take anti-platelet drugs, which have the highest utilization rate of Clopidogrel and Aspirin.Although there are many studies showed that patients taking anti-p]atelet drugs developed gastrointestinal mucosal injury symptoms after taking anti-p｜atalet drugs, but few reports have respectively clarified the gastrointestinal mueosal injury consequences of patients who appear and didn＇t appear gastrointestinal symptoms after taking anti-platalet agents.This has a great contribution to the prevention before disease.

关 键 词：抗血小板药物 阿司匹林 氯吡格雷 胃黏膜损伤 小肠黏膜损伤 

分 类 号：R973[医药卫生—药品]